The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Todays news rns didn't show anything new, apart from more definite time scales on saffron appraisal/production well.
If results ok from it, then shareprice should tick up nicely, allowing more saffron clones to raise revenue.
If results bad, there won't be much love for this company :)
This is more a gamble than an investment atm.
I've bought through ri as I still believe that company has more to give. Still exploration stage mainly and may still be a damp squid but my money is on it rising.
If I am wrong, I will just have to accept my losses here.
Was not a sale. It was a buy from this morning on the back of the RNS.
You can't mention anything negative on here or you will hammered for being a troll, but if you mention it was a 50 million buy, wow what a genius buy.
Whom ever did the buy/sell good luck
Big sell after hours today following on from yesterday's must set some bells ringing.
Why the rns and the proactive presentation today of all days.
Don't be fooled as to what's going on, they need pi's to cough up simple as that, and some on here are helping their cause, are they coughing up?
Fool me once, shame on you, fool me twice, shame on me.
In fairness, it's simply a chunk of the current placing, so expected.
Up again tomorrow, you never know that could have been a buy. Would have been a lot lower price with that volume. You said it was a sell yesterday and look what happened news out up near 8%.
You trolls will never learn BPC is going places this year and next.
It only gets noticed when they think it's a buy such as the 23M sell yesterday.
As for the rns and podcast today that was done purely to stop the sp from free falling to a level where the Open Offer was impossible to get away, next week is going to be interesting.
clearing up for another rise tomorrow, but looks like the price would have been a lot lower at that volume. Would like another 8% rise tomorrow
no one going to mention the £169k sale after hours?
sssshhhhh - no one noticed